The Laryngoscope
June 4, 2026 · via Europe PMC
Does Involvement of Medicine in Care of Head and Neck Free Tissue Transfer Patients Improve Outcomes?
Ziltzer RS, Bulbul MG, Barry E, Chowdhury M, Orabi NA, Chung J, Turner M, Fancy T.
AI summary — for doctors, generated from the abstract only
In a retrospective study of 362 patients, routine involvement of a hospitalist medical service in the postoperative care of head and neck free flap reconstruction patients was associated with roughly half the risk of transfer to a higher level of care, without significant effects on readmission, mortality, or hospital stay.
What was studied
A retrospective cohort study of 362 patients who underwent head and neck free tissue transfer (flap) reconstruction after oncologic surgery (2014-2022), comparing outcomes before (as-needed hospitalist consultation) and after (routine hospitalist involvement starting September 2018) the implementation of routine medical hospitalist service (MHS) involvement in postoperative care, examining transfer to higher level of care, length of stay, 30-day readmission, and 90-day mortality.
Key findings
- Transfer to a higher level of care was significantly lower in the post-intervention (routine MHS involvement) group compared to pre-intervention (risk difference -7.4%, 95% CI -13.7 to -1.02, p = 0.02), roughly halving the relative risk.
- 30-day readmission (risk difference -4.4%, 95% CI -14.0 to 5.3, p = 0.36) and 90-day mortality (risk difference 2.4%, 95% CI -4.1 to 8.8, p = 0.49) did not differ significantly between groups.
- Length of hospital stay decreased by 1.2 days post-intervention, but this difference was not statistically significant (95% CI -3.9 to 1.5, p = 0.39).
Clinical relevance
The findings suggest that routine medical hospitalist involvement in the postoperative care of complex head and neck free flap reconstruction patients may reduce the need for escalation to higher levels of care, which may be relevant to hospitals considering care models for this high-acuity patient population, though the authors call for further studies to confirm these findings.
Who should care
Limitations
This was a retrospective, pre-post (not randomized) comparison at a single institution, so changes in practice patterns or other concurrent quality improvements over the study period could have contributed to the observed difference; the study is explicitly rated level of evidence 3 by the authors, and several secondary outcomes did not reach statistical significance.
Having hospital medicine physicians routinely involved in caring for head and neck free flap surgery patients was linked to a meaningful reduction in patients needing escalated (ICU-level) care, though it didn't significantly change readmission, mortality, or length of stay in this study.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Objectives
To investigate whether routine involvement of the medical hospitalist service (MHS) in postoperative medical management of head and neck cancer (HNC) patients undergoing major ablative head and neck surgery with free tissue transfer (FTT) improves inpatient outcomes.
Methods
This is a retrospective cohort study. Patients undergoing FTT after head and neck oncologic surgery between 2014 and 2022 were identified. Starting September 2018, MHS were involved in the medical care of every FTT patient (post-intervention). Prior to that, MHS were consulted on an as-needed basis (pre-intervention). Outcomes studied included transfer to a higher level of care (LOC), length of hospital stay (LOHS), 30-day readmission, and 90-day mortality. Data were analyzed using linear regression and generalized linear models.
Results
A total of 362 patients were included in this study (mean age 62.3 ± 10.5 and 30.1% females), 32.9% of the cohort being in the pre-intervention group. When comparing the post-intervention to pre-intervention groups, the risk difference (RD) for: (1) transfer to higher LOC was -7.4% (95% CI = -13.7 to -1.02, p = 0.02); (2) 30-day readmission was -4.4% (95% CI = -14.0 to 5.3%, p = 0.36); and (3) 90-day mortality was 2.4% (95% CI = -4.1 to 8.8, p = 0.49). Post-intervention, the LOHS decreased by 1.2 days compared to pre-intervention (95% CI = -3.9 to 1.5, p = 0.39).
Conclusion
Involvement of MHS in the care of patients undergoing FTT halved the relative risk of transfer to higher LOC. There was no significant effect on mortality, readmission, or hospital stay. Further studies are needed to confirm our findings.
Level of evidence: 3
DOI
10.1002/lary.70659
PMID
42244039
PMCID
PMC13569696
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed